These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6323517)

  • 21. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding.
    Anania CA; Stewart EA; Quade BJ; Hill JA; Nowak RA
    Mol Hum Reprod; 1997 Aug; 3(8):685-91. PubMed ID: 9294852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor (EGF) receptors in human chorionic gonadotropin-producing tumor: transplantation in nude mice and the effect of EGF on tumor growth.
    Miyachi Y; Terazono T; Nagao N; Shoji T; Irie M
    J Clin Endocrinol Metab; 1990 Aug; 71(2):329-34. PubMed ID: 2380332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptors in uteroplacental tissues in term pregnancy before and after the onset of labor.
    Gargiulo AR; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1997 Jan; 82(1):113-7. PubMed ID: 8989243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of leupeptin on progestin receptors of human uterine tissues.
    ElDieb MR; Andersen RN
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1007-12. PubMed ID: 6889609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of integrins and cadherins in normal human uterus and uterine leiomyomas.
    Taylor CV; Letarte M; Lye SJ
    Am J Obstet Gynecol; 1996 Aug; 175(2):411-9. PubMed ID: 8765262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.
    Stewart EA; Friedman AJ; Peck K; Nowak RA
    J Clin Endocrinol Metab; 1994 Sep; 79(3):900-6. PubMed ID: 8077380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased binding of epidermal growth factor at preimplantation sites in mouse uteri.
    Brown MJ; Zogg JL; Schultz GS; Hilton FK
    Endocrinology; 1989 Jun; 124(6):2882-8. PubMed ID: 2785911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
    Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
    Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma.
    Matsuo H; Kurachi O; Shimomura Y; Samoto T; Maruo T
    Oncology; 1999 Oct; 57 Suppl 2():49-58. PubMed ID: 10545803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice.
    Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D
    Exp Toxicol Pathol; 2000 Jun; 52(3):195-200. PubMed ID: 10930119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
    Sharara FI; Nieman LK
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy.
    Matsumoto T; Sagawa N; Mukoyama M; Tanaka I; Itoh H; Goto M; Itoh H; Horiuchi M; Dzau VJ; Mori T; Nakao K
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4366-72. PubMed ID: 8954043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth.
    Wolańska M; Bańkowski E
    Eur Cytokine Netw; 2004; 15(4):359-63. PubMed ID: 15627646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
    Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
    Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist.
    Lumsden MA; West CP; Bramley T; Rumgay L; Baird DT
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1299-304. PubMed ID: 2975953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor gene expression in human uterine leiomyomata.
    Brandon DD; Erickson TE; Keenan EJ; Strawn EY; Novy MJ; Burry KA; Warner C; Clinton GM
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1876-81. PubMed ID: 7775635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X; Levens E; Williams RS; Chegini N
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
    Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.